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Abstract
Background: Transmissible agents involved in prion diseases differ in their capacities to target different regions of the
central nervous system and lymphoid tissues, which are also host-dependent.
Methodology/Principal Findings: Protease-resistant prion protein (PrP
res) was analysed by Western blot in the spleen of
transgenic mice (TgOvPrP4) that express the ovine prion protein under the control of the neuron-specific enolase promoter,
after infection by intra-cerebral route with a variety of transmissible spongiform encephalopathies (TSEs) from cattle and
small ruminants. Splenic PrP
res was consistently detected in classical BSE and in most natural scrapie sources, the
electrophoretic pattern showing similar features to that of cerebral PrP
res. However splenic PrP
res was not detected in L-type
BSE and TME-in-cattle, or in the CH1641 experimental scrapie isolate, indicating that some TSE strains showed reduced
splenotropism in the ovine transgenic mice. In contrast with CH1641, PrP
res was also consistently detected in the spleen of
mice infected with six natural ‘‘CH1641-like’’ scrapie isolates, but then showed clearly different molecular features from
those identified in the brains (unglycosylated PrP
res at ,18 kDa with removal of the 12B2 epitope) of ovine transgenic mice
or of sheep. These features included different cleavage of the main PrP
res cleavage product (unglycosylated PrP
res at
,19 kDa with preservation of the 12B2 epitope) and absence of the additional C-terminally cleaved PrP
res product
(unglycosylated form at ,14 kDa) that was detected in the brain.
Conclusion/Significance: Studies in a transgenic mouse model expressing the sheep prion protein revealed different
capacities of ruminant prions to propagate in the spleen. They showed unexpected features in ‘‘CH1641-like’’ ovine scrapie
suggesting that such isolates contain mixed conformers with distinct capacities to propagate in the brain or lymphoid
tissues of these mice.
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Introduction
Transmissible spongiform encephalopathies (TSE) such as
scrapie in sheep and goats, bovine spongiform encephalopathy
(BSE) in cattle and Creutzfeldt-Jakob disease (CJD) in humans, are
associated with the accumulation of an abnormal, host-encoded,
prion protein (PrP) in infected tissues [1]. Whereas the normal
protein (PrPC) is fully sensitive to proteases, the disease-associated
prion protein (PrP
d) is only partly degraded (PrP
res) by removal of
its amino-terminal end. In some of these diseases, such as scrapie,
and after transmission in experimental rodent models, PrP
d can be
detected in the lymphoid tissues that are involved in propagation
of the infectious agent.
To some extent, Western blot studies of PrP
res in TSE-affected
animals reveal distinct molecular features, specifically associated
with the ‘‘strain’’ of infectious agent involved in the disease [2]. A
typical molecular signature of the BSE agent has notably been
identified by Western blot or immunohistochemical analyses of
PrP
d and such methods can be used to identify the possible
presence of BSE in sheep or goats [3,4]. However a few TSE
isolates, showing partial similarities with experimental ovine BSE,
have been described in sheep, with a lower molecular mass of
unglycosylated PrP
res (,18 kDa) in the brain than in most scrapie
cases (,19 kDa), as also found in ovine BSE. This was first
demonstrated in the CH1641 experimental scrapie isolate [5], and
then in a few natural scrapie cases in Great Britain and France
[6,7]. Studies of such ‘‘CH1641-like’’ natural isolates in sheep are
crucial, especially in view of the recent hypothesis that the BSE
epidemic in cattle might have originated from the recycling of an
endogenous bovine prion in an intermediate host, such as sheep
[8,9]. Indeed, novel bovine prions, defined by distinct PrP
res
molecular features with either a higher or lower molecular mass of
PrP
res, in H-type and L-type BSE respectively, than in the classical
food-borne BSE, have recently been identified [10,11]. These
unusual cases of BSE putatively represent sporadic cases, like most
cases of CJD in humans [12].
Most biochemical studies of TSEs so far have relied solely on
the characterization of a main PrP
res fragment, which has a gel
mobility of ,18–21 kDa in its unglycosylated form. However, it
has recently been shown, using C-terminal antibodies in Western
blot studies, that prion discrimination could be facilitated by
identifying additional C-terminal PrP
res fragments. In human
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e10310CJD, a ,13 kDa C-terminal fragment distinguishes type 1 CJD
from most type 2 cases, that also differ in the apparent molecular
masses of the main PrP
res form (,21 or 19 kDa respectively) [13].
In ruminant TSEs, high levels of an additional ,14 kDa
(unglycosylated form) C-terminal PrP
res fragment have been
identified in H-BSE in cattle [14] and in ‘‘CH1641-like’’ isolates
in sheep [15]. This C-terminal PrP
res fragment has not been
detected in L-type and classical BSEs.
Bioassays, performed in wild-type mice to identify prion strains
from TSE isolates, were reported to identify the biological
signature of the BSE agent (incubation periods of the disease,
distribution and features of PrP
d deposits), but the CH1641
source unfortunately failed to transmit the disease to such mice
[5,16]. Both CH1641 and ‘‘CH1641-like’’ natural isolates were
however transmitted in an ovine transgenic mouse model
(TgOvPrP4), showing similar PrP
res molecular features (i.e. a
low apparent molecular of unglycosyslated PrP
res (,18 kDa)) in
the brain of both transgenic mice and sheep [17,18]. Regarding
the unusual forms of bovine prions, L-type BSE was successfully
transmitted to this ovine transgenic mouse model, whereas H-
type BSE failed to transmit [19], and the reverse results were
obtained in C57Bl/6 mice [9,11]. Overall, molecular analyses of
PrP
res from the mice brains showed that the differences in
molecular mass of the main PrP
res product, as in the natural host
of the disease, were faithfully maintained, together with the
identification and proportions of the C-terminal PrP
res fragment,
if present [14]. The latter allowed the H-type to be clearly
distinguished from classical BSE in C57Bl/6 mice [14] and
‘‘CH1641-like’’ scrapie (or CH1641) from both classical and L-
type BSEs in ovine transgenic mice [15].
To further our understanding of ruminant TSEs and of their
possible relationship, we therefore investigated the detection and
biochemical features of PrP
res in the spleen of TgOvPrP4 mice
compared to those previously described in the mouse brain.
Results
PrP
res is identified in the spleen of ovine transgenic mice
infected with most ruminant TSE sources
Western blot analyses have revealed PrP
res in the spleen of
TgOvPrP4 ovine transgenic mice infected with most ruminant
TSE sources (Table 1). These results were obtained at first passage,
after intra-cerebral inoculation of 10% brain homogenates from
TSE-infected cattle, sheep or goat.
Table 1. Detection and phenotypic features of PrP
res in the spleen of TgOvPrP4 mice infected with TSE sources from cattle and
small ruminants.
TSE sources
Nb PrPres positive mice in the
spleen Molecular phenotype
(1)
(+/2)
(2)
Spleen Brain
BSE in small ruminants
Ovine BSE (ARQ/ARQ)
(3) 3/4 l (2)l
Ovine BSE (ARR/ARR)
(3) 3/3 l (2)l
Goat BSE 3/3 l (2)l
TSEs in cattle
C-type 5/5 l (2)l
L-type 0/5 - l
TME 0/6 - l
Non «CH1641-like» scrapie
SSBP/1 4/5 h (2)h
Natural classical scrapie
O69 4/5 h (2)h
O111 4/4 h (2)h
O171 5/6 h (2)h
‘‘CH1641-like’’ scrapie
CH1641 0/7 - l
Natural isolates
O104 5/5 h (+) l and/or h
TR316211 5/5 h (+)l
06-825 4/4 h (+)l
06-017 5/5 h (+)l
06-287 4/4 h (+)l
06-412 4/4 h (+)l
(1)h and l refers to the ,19 kDa or ,18 kDa molecular masses of PrP
res, when detectable.
(2)higher (+) or lower (2) molecular mass of PrP
res in spleen compared to brain PrP
res.
(3)amino-acids encoded at codons 136, 154 and 171 of the prnp gene.
doi:10.1371/journal.pone.0010310.t001
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ovine scrapie, including the SSBP/1 experimental isolate and
three natural classical scrapie isolates, were PrP
res positive. These
four isolates contain PrP
res of high apparent molecular mass
(,19 kDa) in the brain, in sheep and after transmission in
TgOvPrP4 mice. Analyses of the spleen of these mice, showed a
slightly lower apparent molecular mass than in brain, similarly
with both 12B2 (Figure 1A) and Sha31 (Figure S2) monoclonal
antibodies. Statistical analyses confirmed that the molecular
masses of the bi-, mono- and un-glycosylated bands were
significantly lower for the spleen than for the brain. Estimates of
the mean differences of molecular masses using Sha31 antibody
were 20.66 kDa (p,0.0001), 20.79 kDa (p,0.0001) and
20.36 kDa (p,0.0001) for the bi-, mono- and un-glycosylated
bands respectively. However, strong 12B2 labeling showed that, as
for brain PrP
res, the 12B2 epitope had not been removed following
proteinase K digestion (Figure 1A). Examination on a same gel of
the individual spleen samples showed a similar PrP
res profile in all
the scrapie-infected mice of the same experimental group.
The spleens of 14/15 mice infected with classical BSE were
PrP
res positive whether they had been infected from cattle, from a
goat naturally infected with the BSE agent, or from sheep
(homozygous A136R154Q171 and A136R154R171 genotypes) exper-
imentally infected with classical BSE (Figure 1B). The apparent
molecular mass of the unglycosylated splenic PrP
res was again
similar in all the mice examined and lower (0.25–0.4 kDa
difference) than that of brain PrP
res, which had a low apparent
molecular mass (,18 kDa), and was only faintly labeled by 12B2
antibody (data not shown).
Some TSE strains show a reduced splenotropism in ovine
transgenic mice
None of the mice inoculated with L-type BSE and TME-in-
cattle or with the CH1641 experimental scrapie isolate were PrP
res
positive in the spleen (Table 1, Figure 1C and 2A). However, all
mice inoculated with these three TSE sources were PrP
res positive
in the brain. Mice inoculated with H-type BSE were negative in
both brain and spleen.
Splenic PrP
res shows major differences with brain PrP
res
in ‘‘CH1641-like’’ natural scrapie isolates. We then studied
six ‘‘CH1641-like’’ natural isolates, characterized by a low
apparent molecular mass in the brain of sheep (,18 kDa),
similar to that found in experimental ovine BSE or CH1641.
We found that, in contrast with CH1641, all mice infected with
the six ‘‘CH1641-like’’ natural scrapie isolates (27/27), were
strongly PrP
res positive in the spleen by Western blot (Table 1).
The presence of PrP
d was also confirmed by
immunohistochemistry using SAF84 antibody (Figure S1).
However, the splenic PrP
res in all these mice clearly showed a
,19 kDa molecular mass (Figure 2A) associated with strong 12B2
labeling (Figure 2B), as previously described in all sources of
scrapie with a ,19 kDa PrP
res in brain. This pattern clearly
differed from that found in the brains of all mice infected with the
five A136 R154 Q171 homozygous sheep, which showed a ,18 kDa
PrP
res [15]. For the single case identified in a V136 R154 Q171
homozygous sheep (O104), three of the five mice analyzed showed
a predominant ,18 kDa pattern in the brain, one a predominant
,19 kDa PrP
res pattern (mouse nu5 in Figure S2) whereas the fifth
exhibited a mixed pattern [15,17]. Statistical analyses confirmed
that the molecular masses of the bi-, mono- and un-glycosylated
bands were significantly higher for the spleen than for the brain
(Figure S2). Estimates of the mean differences of molecular masses
using Sha31 antibody were respectively +0.32 kDa (p=0.012),
+0.45 kDa (p=0.014) and +0.65 kDa (p=0.0005) for the bi-,
mono- and un-glycosylated band.
In addition, analyses of splenic PrP
res with SAF84 antibody not
only confirmed its ,19 kDa molecular mass (Figure 2D), but also
showed that the C-terminal PrP
res fragments remained undetect-
able in the spleen (Figure 2C). This was evidenced by the absence
of the ,14 kDa unglycosylated band and the ,18 kDa mono-
glycosylated band (see arrow in Figure 2C) and the lower
proportions of the 22–25 kDa band (compare bands indicated
by head arrows in Figure 2C and 2D). This latter band results
from overlapping of the diglycosylated C-terminal PrP
res product,
when present, and the monoglycosylated PrP
res derived from the
main PrP
res product. These C-terminal fragments were specifically
Figure 1. Western blot analysis of PrP
res in the spleen and brain
of TgOvPrP4 mice. PrP
res from the spleen (lanes S) and brain (lanes B)
was extracted from TgOvPrP4 mice infected with classical scrapie or
bovine TSEs. PrP
res was detected using Sha31 (panels B and C) or 12B2
(panel A) antibody. Note that the equivalent tissue quantities loaded
per lane, indicated by figures at the bottom of each panel (in tenths of
mg), were much higher from the spleens than from the brain in L-type
BSE (506) and TME-in-cattle (2006). Bars to the left indicate the 29.0
and 20.1 kDa marker positions.
doi:10.1371/journal.pone.0010310.g001
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res in the mouse
brains from ‘‘CH1641-like’’ natural isolates [15].
Discussion
This investigation of the possible detection of PrP
res by Western
blot in the spleens of TgOvPrP4 ovine transgenic mice infected
with an extended panel of ruminant TSE sources, confirms that
PrP
res frequently accumulates in the spleen of TgOvPrP4 mice
infected by intra-cerebral route and extends our earlier observa-
tions [20]. The apparent molecular mass of splenic PrP
res was
slightly lower than that accumulated in the brain, with both BSE
and scrapie, as previously reported in scrapie-infected sheep [21]
or in humans with variant CJD [22]. This presence of PrP
res was
an unexpected finding since RT-PCR and protein expression
analyses by Western blot had failed to detect expression of the prnp
gene in non nervous tissues in TgOvPrP4 mice during analyses of
the entire spleen [20,23]. PrPC expression was also undetectable
in the lymphoid tissues of uninfected mice in a similar transgenic
mouse model expressing hamster PrP under the control of the
neuron-specific enolase (NSE) promoter. Western blot analysis of
the spleen of mice intra-peritoneally infected with the 263K
scrapie strain had also revealed low levels of a band consistent with
PrP
res, with a lower apparent molecular mass than in the brain
[24]. As PrPC was detected in the peripheral nerves in both
hamster and ovine transgenic mouse models, it was hypothesized
that PrP
d accumulation in the spleen could result from
anterograde transport from the brain to the spleen [20,24].
However, in TgOvPrP4 mice, PrP
d accumulation in the spleen
was identified by immunohistochemistry in germinal centers in
dense areas, reminiscent of follicular dendritic cell clusters [20], as
confirmed in the ‘‘CH1641-like’’ natural scrapie isolates in this
study (Figure S1). Expression of low levels of PrPC in the spleen, in
particular cell types such as the follicular dendritic cells, cannot be
fully excluded in either model, and could have remained
undetectable in analyses of the entire spleen. The hypothesis of
prion replication in particular cell types expressing PrPC, if these
are present, remains a possibility. Interestingly, a recent study
however showed that the degree of PrP
d accumulation in the
spleen of experimentally infected sheep did not depend on the
PrPC expression level [25]. The major sites of PrP
d accumulation
were the lymphoid follicles, in which PrP mRNA levels were low,
suggesting that PrP
d may originate from another site.
Transmission studies then revealed that some TSE sources,
unlike classical BSE and most scrapie sources, exhibited reduced
splenotropism in TgOvPrP4 mice. Importantly, our study was
nevertheless limited to the detection of PrP
res by Western blot in
the spleen of transgenic mice, and further studies would be
required to evaluate the infectivity of the spleen, also in TSE
sources that did not show detectable PrP
res. Several parameters
related to the experimental conditions used in our study might
have influenced these observations. Firstly, our results could be
affected by the species barriers and passage history of the inocula.
However, all the TSE sources were examined at a first passage in
TgOvPrP4 mice, from cattle, sheep or goat, to limit these possible
effects. In the case of the bovine TSE sources, we cannot exclude
the possibility that the reduced splenotropism of BSE-L or TME-
in-cattle was, at least in part, the result of a species barrier
phenomenon, although our data clearly indicate clear differences
with classical BSE examined in these same conditions.
The failure to detect PrP
res with some TSE sources might be
affected by the infectivity levels of the inocula. For example, in
wild-type mice, PrP
res was detected in the spleen of IM/Dk mice
(sinc p7) inoculated with 10% brain homogenates of the 87V
strain, but not in VM/Dk mice (also sinc p7) inoculated with 1%
brain homogenates, even if terminally infected [26]. The infectious
Figure 2. Western blot analysis of ‘‘CH1641-like’’ scrapie isolates in TgOvPrP4 mice. PrP
res in the spleen (lanes S in panels A and B, panel
D) and brain (lanes B in panels A and B, panel C) were compared in TgOvPrP4 mice infected with natural ‘‘CH1641-like’’ and experimental CH1641
scrapie isolates. PrP
res was detected using Sha31 (panel A), 12B2 (panel B) or SAF84 (panels C and D) antibody. Note that the equivalent tissue
quantities loaded per lane, indicated by figures at the bottom of each panel (in tenths of mg), were much higher from the spleen than from the brain
in CH1641 (306). The arrow indicates the position of the monoglycosylated band of the C-terminal PrP
res product and the head arrows indicate the
22–25 kDa band. Bars to the left indicate the 29.0 and 20.1 kDa marker positions in panels A and B, as well as the 14.3 kDa marker position in panels
C and D.
doi:10.1371/journal.pone.0010310.g002
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TgOvPrP4 mice, but the sources with undetectable splenotropism
(BSE-L, TME-in-cattle and CH1641) showed comparable or
higher levels of PrP
res than the other sources in each experimental
group (bovine and ovine isolates), as assessed by ELISA measures
of PrP
res (data not shown).
All the experiments were also performed solely by intra-cerebral
route, this being the most efficient way of experimentally transmitting
a prion disease. However, the spleen is known to be readily infected
afterintra-cerebralinoculation as much of the inoculumescapes from
the central nervous system [26,27]. As we showed, unexpectedly, that
TgOvPrP4 mice couldalso be infected by intra-peritoneal route [20],
it would be interesting to analyze the possible transmissibility of these
TSE sources and the location of PrP
res accumulation after challenge
by peripheral routes. Beside the route of inoculation, our study
involved the use of transgenic mice, which largely differ from the
natural hosts of prion diseases,such as sheep, by the random insertion
of transgene copies under the control of non prion regulatory
sequences and in a murine genetic background.
The distribution of the infectious agent and/or PrP
d is strongly
influenced by both the TSE strain and the host of the disease
[26,28]. The identification of distinct lymphotropisms of rumi-
nants TSEs, that is shown in this study in ovine transgenic mice, is
not unprecedented and was also demonstrated by experimental
transmissions in ruminants. The pathogenic behaviour of classical
BSE is strongly influenced by the host, and showed much larger
lymphotropism in homozygous A136 R154 Q171 sheep than in cattle
[29,30]. In contrast to classical BSE, recent findings in
homozygous A136 R154 Q171 sheep experimentally infected with
L-type BSE by intra-cerebral route did not show any evidence of
prion accumulation in lymphoid tissues [31]. With regard to
TME, whereas reduced extraneural invasion has been shown to be
a hallmark of TME infection in mink [32], the TME agent also
remained undetectable in the spleen of goats experimentally
infected by intra-cerebral route [33]. Finally, transmission
experiments with ovine scrapie sources showed that, in contrast
to classical BSE or most classical scrapie sources, CH1641 did not
readily replicate in the lymphoid tissues after intra-cerebral
inoculation [34] and attempts to infect sheep with CH1641 by
peripheral routes were also unsuccessful [16].
Our results also demonstrate that PrP
res, with distinctly different
features from the PrP
res observed in the brain, could be identified
in the spleen of mice infected with ‘‘CH1641-like’’ natural isolates,
whereas it could not be detected in the spleen of CH1641-infected
mice. These differences are apparent in the spleen, not only as a
different N-terminal cleavage of the main PrP
res product which
migrates at ,19 kDa and does not remove the 12B2 epitope, but
also by the absence of a detectable C-terminally cleaved PrP
res
fragment, comparable to that previously described in the brains of
these mice (,19 kDa PrP
res, 12B2 labelled and presence of C-
terminal PrP
res product) [15]. These differences are unlikely to
result from the specific processing in different tissues, since they
are only, but consistently, observed in ‘‘CH1641-like’’ isolates and
strikingly differ from that found in all other TSE sources. This
seems to reflect the presence in ‘‘CH1641-like’’ scrapie of mixed
conformers with different abilities to propagate in the spleen and
brain or a distinct conformation of PrP
d between spleen and brain
in these particular isolates. Possible coexistence of both ,19 kDa
and ,18 kDa PrP
res had already been suggested when variable
proportions of these two PrP
res molecular types were observed in
the brains of TgOvPrP4 mice infected with two ‘‘CH1641-like’’
isolates (O100, O104) identified in V136R154Q171 homozygous
sheep [6,17]. In these two sheep, and in contrast with classical
BSE, PrP
d was clearly identified by immunohistochemical labeling
using P4 antibody (93–99 PrP region), not only in some of the
brain stem nuclei, such as the dorsal nucleus vagus (X), but also in
the lymphoid tissues [6]. The coexistence of ,18 kDa and
,19 kDa PrP
res has also recently been described in a British
sheep, each PrP
res phenotype originating from a different brain
area [7] and similar results were obtained in a cow that had been
intra-cerebrally infected with a pool of British ovine scrapie cases
[35]. Our data thus most probably reflect the coexistence of two
PrP
res molecular types in these ‘‘CH1641-like’’ natural scrapie
isolates, a situation which brings to mind the possible co-
occurrence of type 1 and type 2 PrP
res in some human CJD
patients [36]. Whereas the ,19 kDa PrP
res readily accumulates in
the mouse spleen, as shown here for all scrapie sources that
showed a ,19 kDa PrP
res in the brain of sheep, our data clearly
indicate that the ,18 kDa PrP
res from ‘‘CH1641-like’’ natural
isolates does not accumulate in the spleen in this mouse model.
These results are consistent with those observed in TgOvPrP4 with
the CH1641 experimental isolate that failed to propagate in the
spleen, and also with those previously reported in the lymphoid
tissues of CH1641 experimentally infected sheep [4]. This distinct
splenotropism of prions derived from a single TSE source
ressembles the situation in TME, in which the DY strain isolated
in hamster, associated with a ,18 kDa PrP
res, failed to replicate in
the lymphoid tissues, in contrast to the HY strain associated with a
,21 kDa PrP
res [37]. More recently, a study of four human vCJD
cases inoculated into human transgenic mice, showed that one
case produced an alternate PrP
res pattern in half of the mice, like
that of sporadic CJD (sCJD), whereas all the mice exhibited the
typical vCJD molecular pattern in their spleen [38]. Despite this
PrP
res pattern of sporadic CJD in the brain, only the PrP
res pattern
of vCJD was again detected in the spleen after the second passage
in such mice, suggesting that the vCJD agent was still propagated
as a minor component in the brains, but was preferentially
replicated in the spleen. Overall, this example in a human disease
shows that distinct propagation of prions in cerebral and lymphoid
tissues of the same TSE-infected animal is not unprecedented.
Finally, although the precise cellular origin of splenic PrP
d in
TgOvPrP4 ovine transgenic mice still needs to be determined, our
data suggest that this ovine transgenic mouse model properly
reflects the behavior of the different TSE agents in sheep with
regard to their capacity to propagate in the spleen. The
unexpected behavior of natural ‘‘CH1641-like’’ ovine TSE
isolates, in which prions distinct from those found in the brain
accumulated in the spleen of TgOvPrP4 mice, suggests the
possibility of a mixture of two strains. The TSE agents associated
with the two PrP
res phenotypes identified in the brain or spleen still
need to be biologically characterized and, more generally
speaking, the basic mechanisms underlying the variable tissue or
cell tropisms of different prions inside the central nervous system
and in the peripheral tissues are still little understood.
Materials and Methods
Ethics statement
Experiments were performed in the Biohazard prevention area
(A3) of the author’s institution with the approval of the Rho ˆne-
Alpes Ethical Committee for Animal Experiments and following
the guidelines of the French Ethical Committee (decree 87-848)
and European Community Directive 86/609/EEC.
Mouse transmission studies
Experimental transmissions of a variety of natural or experimen-
tally-produced TSE sources from small ruminants and cattle
(Table 1) were previously reported, after intra-cerebral inoculation
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PrP protein (A136R154Q171 allele) under the control of the neuron-
specific enolase (NSE) promoter [23]. The TSE sources from small
ruminantsincluded(i)naturalorexperimental scrapie,includingthe
SSBP/1 and CH1641 experimental scrapie isolates [18,23], (ii)
‘‘CH1641-like’’ natural scrapie, characterized by a similar apparent
molecular mass of PrP
res to that of ovine BSE or CH1641
experimental scrapie isolate (,18 kDa) [15,17,39], and (iii) BSE
[18,40,41].Allthe ‘‘CH1641-like’’ natural isolates were identifiedin
A136 R154 Q171 homozygous sheep, except the O104 isolate which
was from a V136 R154 Q171 homozygous sheep [6,39]. From cattle,
the food-borne classical BSE, the H-type and L-type atypical forms
of BSE, as defined by their molecular differences with classical BSE,
and transmissible mink encephalopathy (TME) experimentally
transmitted to cattle were included [15,19]. Only H-type BSE
consistently failed to transmit the disease to TgOvPrP4 mice, as
assessed by the absence of PrP
res in the brain [19].
Biochemical studies of PrP
res
PrP
res was extracted and detected as previously described [15],
from mice infected at first passage performed by inoculation of
10% brain homogenates with the different TSE sources from
ruminants. PrP
res was extracted from the entire spleens by treating
the spleen homogenates with collagenase (100 mg/100 mg spleen
in a 1 ml total volume) and DNAse (64 mg/100 mg spleen in a
1 ml total volume) for 1h at 37uC, then with proteinase K (24 mg/
100 mg spleen in a 1.2 ml volume) for 1h at 37uC. After 15%
SDS-PAGE and electro-blotting on nitrocellulose membranes,
PrP
res was detected with 12B2 (340 ng/ml) (kindly provided by Dr
J. Langeveld, CIDC-Lelystad, The Netherlands), Sha31 (1/10
from TeSeE Bio-Rad sheep and goats kit)(Bio-Rad, France) or
horseradish peroxidase-labeled SAF84 (500 ng/ml)(SPI-Bio,
France), against the 93-WGQGG-97, 148-YEDRYYRE-155 and
167-RPVDQY-172 ovine PrP sequences respectively. These
antibodies allow detailed epitope mapping of the protease-resistant
prion protein accumulating in the infected tissues, and molecular
discrimination between different strains [7,15,34]. Peroxidase-
labelled conjugate anti-mouse IgG (H+L)(1/2500 in PBST)(ref
1010-05)(Clinisciences, France) was used to detect 12B2 and
Sha31 antibodies. Streptavidin (5 ng/ml)(S5512) was added to the
conjugate solution. Bound antibodies were then detected by direct
capture with the Versa Doc (Biorad) analysis system, using the
ECL chemiluminescent substrate (Amersham, France). Quantita-
tive studies were performed using Quantity One (Biorad) software
and the apparent molecular masses were measured by comparing
the positions of the PrP
res bands with a biotinylated marker
(B2787)(Sigma, France).
The profiles of PrP
res extracted from the individual spleens (17
and 27 mice respectively for ‘‘non CH1641-like’’ and ‘‘CH1641-
like’’ ovine scrapie, 14 mice for classical BSE) were first compared
by loading the samples of each mouse belonging to the same
experimental group on the same gel, as performed for the brains of
these mice in previously published studies. The PrP
res profiles from
brain and spleen were then compared by performing Western blot
analyses of the brain and spleen in a panel of individual mice
loaded lane by lane on the gel (see Figure 1). This allowed accurate
determination of the differences in molecular masses of the PrP
res
bands between brain and spleen from the same animal as
indicated by ‘‘+’’ (higher in the spleen) or ‘‘2’’ (lower in the
spleen) in Table 1.
Statistical analyses
For ‘‘CH1641-like’’ and ‘‘non CH1641-like’’ ovine isolates, 17
and 46 measures of the molecular masses were made respectively
for the di-, mono- and unglycosylated bands, on the spleen and
brain of 9 and 13 mice respectively, with one to four replications
per mouse. Figure S2 shows the differences of molecular masses
between spleen and brain for the three PrP
res glycoforms from the
22 mice infected with the two categories of isolates.
Six linear mixed effects models (one model for each combina-
tion isolate/band) were adjusted to estimate the difference of
molecular mass between spleen and brain. A model was written as
follows :
yiki~bzbizeiki
with yiki the ki
th replication of the difference of molecular mass
between spleen and brain of the mouse i, b the mean effect of the
difference of molecular mass and bi a random effect for the mouse
effect with bi,N(0,s2
b) and eiki,N(0,s2). The parameter b was of
particular interest as it gives an estimation of the difference of
molecular masses between spleen and brain and the p-value of the
t-test associated with b was used to assess if it was significantly
different from zero. Assessment of the models was done by
graphical examination of the residuals.
Statistical analysis was performed with the package nlme (Jose
Pinheiro, Douglas Bates, Saikat DebRoy, Deepayan Sarkar and
the R Core team (2009). nlme: Linear and Nonlinear Mixed
Effects Models. R package version 3.1–96) of the R software (R
Development Core Team (2009). R: A language and environment
for statistical computing. R Foundation for Statistical Computing,
Vienna, Austria. ISBN 3-900051-07-0, URL http://www.
R-project.org).
Supporting Information
Figure S1 PrP
d immunohistochemical analysis of TgOvPrP4
mouse spleen. Mice were infected with the SSBP/1 (left panel) or
05-825 natural scrapie source (right panel), using SAF84
monoclonal antibody [20,42]. PrP
d is revealed by the presence
of black deposits of DAB intensified by using chloride nickel
within the follicles. Both the location and shape of the positively
labeled-cells are totally similar to those described in previous
studies in this model [20] and are probably follicular dendritic
cells.
Found at: doi:10.1371/journal.pone.0010310.s001 (1.58 MB TIF)
Figure S2 Differences of molecular masses of the PrP
res
glycoforms between the spleen and brain of individual mice
infected by ‘‘CH1641-like’’ or ‘‘non CH1641-like’’ ovine scrapie
isolates. PrP
res extracted from brain and spleen of individual mice
(Mouse) were loaded lane by lane and differences of the three
PrP
res glycoforms were measured by repeated (1–46)(Rep)
Western blot analysis.
Found at: doi:10.1371/journal.pone.0010310.s002 (10.50 MB
TIF)
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